Parkinson's UK Fellowship Award
18 October 2010
Dr Patrick Lewis (
The research, funded for £250,000 over the next three years, will provide an insight into the underlying mechanisms operating in Parkinson's disease.
Dr Lewis commented that "LRRK2 is one of the most promising
drug targets that has been revealed to us by studying the molecular
genetics of Parkinson's disease. This proposal will provide invaluable
information as to what aspects of the biology of LRRK2 we need to target
in order to counteract the deleterious impact that mutations in this
protein can cause".
He will be discussing his research at the upcoming Parkinson's UK conference to be held in York at the end of October.
read more >> Parkinson's UK | IoN Department of Molecular Neuroscience